DefiniGEN generate high-quality, phenotypically relevant and bespoke disease models.

Our induced pluripotent stem cell (iPSC) OptiDIFF platform enables the generation of high-quality wild-type and disease cell models. We can produce mature cells which recapitulate a range of disease phenotypes and are being adopted for preclinical evaluation studies.

DefiniGEN offer the ability to develop custom models for screening or characterizing lead compounds for indications that have previously been difficult to study.